ShareValue scores for HDST.TA: Valuation 59, Quality 47, Growth 50, Health 51.
HDST.TATASE
Hadasit Bio
₪72.50
(0.00%)
HDST.TATASE
Hadasit Bio
₪72.50(0.00%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
7% to 17%
Rating
Trap Risk
Return
7% to 17%
Valuation
59
Fair Value
Price vs Value
Quality
47
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
51
Moderate
Financial Stability
Momentum
58
Neutral
Price Trend
Company Details
About
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer. It offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. HBL - Hadasit Bio-Holdings Ltd was incorporated in 2005 and is based in Jerusalem, Israel.
Market Cap$804M
P/E RatioN/A
Dividend YieldNone
Sector Rank#1161
Score Analysis
AI Investment Thesis
Data as of:Jun 29, 2026
|Last calculated:Jun 29, 2026